Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
341. |
ECCT/16/08/01 | A5349/TBTC S31 A5349/TBTC S31 “Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial” |
Principal Investigator(s) 1. Abraham Mosigisi Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) |
View |
342. |
ECCT/16/07/06 | Cups or Cash for Girls Trial Menstrual cups and cash transfer to reduce sexual and reproductive harm and school dropout in adolescent schoolgirls in western Kenya: a cluster randomised controlled trial |
Principal Investigator(s) 1. Penelope Anne Phillips-Howard 2. Daniel Oluoch Kwaro Site(s) in Kenya Siaya County |
View |
343. |
ECCT/16/07/05 | HESTIA 1 Multicentre, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric patients with sickle cell disease |
Principal Investigator(s) 1. Jessie Nyokabi Githanga 2. Videlis Nduba 3. Bernhards Ragama Ogutu Site(s) in Kenya 1. Gertrude’s Children’s Hospital (Nairobi City county) 2. Kemri CRDR research center at Chandaria Health Centre Dagoretti (Nairobi City county) 3. Clinical Research Annex at the Siaya County Referral Hospital (Siaya county) 4. Kondele Children’s Hospital, KEMRI – Centre for Clinical Research (Kisumu county) |
View |
344. |
ECCT/16/07/03 | CYP STUDY Primaquine metabolism and its association with CYP2D6 and CYP2C19 genotypes among adults living within Seme and Kisumu West sub-counties of Kisumu County, Western Kenya |
Principal Investigator(s) 1. BEN ANDAGALU 2. BEN ANDAGALU Site(s) in Kenya KOMBEWA CLINICAL RESEARCH CENTRE |
View |
345. |
ECCT/16/07/02 | A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events A Randomized Trial of Inflienza Vaccine to Reduce Adverse Vascular Events |
Principal Investigator(s) 1. Mark Loeb Site(s) in Kenya The Aga Khan University Hospital |
View |